Is high calcium a sign of cancer
Pro Research Analysisby 
Searched over 200M research papers
High Calcium as a Sign of Cancer
Introduction to Hypercalcemia and Cancer
Hypercalcemia, or elevated calcium levels in the blood, is a condition that can be associated with various types of cancer. This article explores the relationship between high calcium levels and different cancers, including breast, ovarian, and prostate cancers, and discusses the potential of hypercalcemia as a biomarker for cancer detection and prognosis.
Breast Cancer and Calcium Signaling
Breast cancer cells often manipulate calcium signaling to support their survival and progression. Increased expression of calcium channels, G-protein-coupled receptors (GPCRs), pumps, and enzymes leads to elevated intracellular calcium levels, which are crucial for malignant functions such as migration, invasion, proliferation, and metastasis . Additionally, patients with advanced and metastatic breast cancer frequently develop hypercalcemia due to increased bone resorption driven by tumor-derived osteolytic factors .
Ovarian Cancer and Serum Calcium Levels
Several studies have shown a significant association between high serum calcium levels and ovarian cancer. Women who develop ovarian cancer often exhibit increased serum calcium and decreased serum albumin levels . Prospective studies have found that higher serum calcium levels are linked to an increased risk of both incident and fatal ovarian cancer Weingarten2008Keum2015. These findings suggest that serum calcium could serve as a biomarker for early detection and prognosis of ovarian cancer.
Prostate Cancer and Hypercalcemia
Research indicates that high serum calcium levels may also be associated with an increased risk of fatal prostate cancer. Men in the highest tertile of serum calcium levels have been found to have a more than 2.5-fold increased risk of fatal prostate cancer compared to those in the lowest tertile . This suggests that monitoring serum calcium levels could help identify men at higher risk for this disease.
Hypercalcemia in Other Cancers
Hypercalcemia is a common metabolic disorder in patients with advanced-stage cancers, including hematological malignancies like multiple myeloma and non-Hodgkin lymphoma, as well as solid tumors such as renal and breast carcinomas . The condition is often a sign of poor prognosis and can be caused by various mechanisms, including osteolytic activity, parathyroid hormone-related peptide (PTHrP) secretion, and extrarenal production of calcitriol .
Conclusion
High calcium levels in the blood can be a significant indicator of various cancers, including breast, ovarian, and prostate cancers. The association between hypercalcemia and cancer highlights the potential of serum calcium as a biomarker for early detection and prognosis. Further research is needed to confirm these findings and to explore the mechanisms underlying the relationship between calcium and cancer progression. Monitoring and managing hypercalcemia in cancer patients can improve their quality of life and potentially enhance treatment outcomes.
Sources and full results
Most relevant research papers on this topic
Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps.
Calcium supplementation may contribute to a moderate degree of prevention of colorectal adenomatous polyps, but the evidence is insufficient to recommend its general use to prevent colorectal cancer.
Serum Calcium and Incident and Fatal Prostate Cancer in the National Health and Nutrition Examination Survey
High serum calcium levels or factors associated with them (e.g., high serum parathyroid hormone) increase the risk for fatal prostate cancer.
Calcium, vitamin D and cancer.
Low vitamin D and inadequate calcium intake are significant risk factors for various cancers, with combined supplementation being necessary for optimal cancer prevention.
Prospective studies of total and ionized serum calcium in relation to incident and fatal ovarian cancer.
Higher serum calcium levels may be a biomarker of ovarian cancer, with a 63% higher risk for ovarian cancer with each 0.1 mmol/L increase in total serum calcium.
Calcium intake and colorectal adenoma risk: Dose‐response meta‐analysis of prospective observational studies
Higher calcium intake may decrease the risk of colorectal adenomas, particularly high-risk adenomas, across a wide range of intake levels.
Diagnosis, Pathophysiology and Management of Hypercalcemia in Malignancy: A Review of the Literature
Hypercalcemia in malignancy is a common, life-threatening metabolic disorder in advanced cancer patients, and early diagnosis and treatment can improve symptoms and quality of life.
Calcium Intake and Prostate Cancer Among African Americans: Effect Modification by Vitamin D Receptor Calcium Absorption Genotype
High intestinal absorption of calcium may link prostate cancer risk to increased prostate cancer risk, with poor absorbers having a significantly lower risk of advanced prostate cancer.
DOI